Norovirus is a highly contagious virus that is the leading cause of acute gastroenteritis (stomach bug) and foodborne illness in the U.S., striking people of all ages with sudden bouts of severe nausea, vomiting, stomach pain, and diarrhea.

Norovirus remains a formidable public health challenge, causing millions of cases of acute gastroenteritis annually. Despite its widespread impact, there is currently no approved vaccine to prevent acute gastroenteritis caused by the norovirus. To combat this persistent virus clinical trials are imperative to develop an effective norovirus prevention vaccine.

ENCORE Research Group is conducting a Phase 3 clinical research study to evaluate the effectiveness and safety of an investigational vaccine to prevent norovirus acute gastroenteritis.

You may be eligible to participate if you:

• Are 18 or older
• Do NOT have a diagnosis of chronic symptomatic gastrointestinal disease, including IBS, colitis, esophageal reflux, or any other medical condition that is associated with symptoms of regular vomiting or diarrhea
• Are NOT currently pregnant or breastfeeding

There are additional criteria to meet to qualify for this study. Volunteers who qualify for our study will receive study-related investigational vaccines, medical exams at no cost, and a stipend for time and travel. No health insurance is required to participate.

For more information call

904-730-0166

Or sign up below, and our friendly staff will call you!

Read the latest posts by our expert clinical staff!